Join us March 7, 2026 for the UF Building Bridges: AYA Oncology and Oncofertility Conference!
Join us for an unparalleled educational experience tailored specifically to healthcare professionals who treat Adolescent and Young Adult (AYA) cancer patients and survivors. Our expert speakers will delve into the latest research and breakthroughs in oncology care, highlighting innovative approaches to optimizing treatment and fertility preservation.
Leverage the Power of Oncofertility
Discover the profound impact of cutting-edge scientific advances on AYA oncology and oncofertility, and gain a deeper understanding of the reproductive risks associated with cancer therapies. Our conference will empower you with the knowledge and inspiration to help AYA cancer survivors build families and live fulfilling lives.
Earn AMA Category 1 PRA Credit and More
Stay up-to-date with the latest developments in AYA oncology and oncofertility, and earn valuable continuing education credits for attending this exceptional event. Our conference is designed to benefit not only physicians, but also nurses, APPs, social workers, and the entire oncology care team.
Learning Objectives:
At the conclusion of this conference, attendees should be able to:
- Describe the framework for providing patient-centered care in oncology and the value of interdisciplinary collaboration among healthcare professionals caring for Adolescent and Young Adult (AYA) patients.
- Identify the critical relationship between AYA oncology providers and fertility preservation services, emphasizing strategies to bridge existing gaps and improve coordination of care.
- Recognize the unique medical, psychosocial, and survivorship issues that affect AYA cancer patients and survivors.
- Discuss the distinct biological and developmental characteristics of AYA oncology patients and the implications for treatment planning and delivery.
- Determine which patient populations may benefit from fertility preservation services and evaluate the available fertility preservation options within the context of cancer treatment.